Photo of Leroy-Fong Liu

View Scopus Profile

Leroy-Fong Liu

Professor

  • 33011 Citations
  • 85 h-Index
1975 …2018
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • Postdoctoral Training
  • University of California at San Francisco (with Bruce Alberts)
  • Department of Biochemistry & Biophysics (1978-1980)
  • Harvard University (with Dr. James C. Wang)
  • Department of Molecular and Cellular Biology (1977-78)
  • Undergraduate
  • Graduate (with Dr. James C. Wang)
  • University of California, Berkeley (1973-77) Ph. D. in Biophysics
  • National Taiwan University, Taipei, Taiwan B. S. in Chemistry (1967-71)

Experience

  • Adjunct Professor and Vice President (2013-present)
  • Taipei Medical University
  • Professor and Chair (1992-2012) and Professor (2012 to 2014) of Pharmacology
  • UMDNJ-Robert Wood Johnson Medical School (now Rutgers University)
  • Assistant (1980-1984), Associate (1984-1988) and Full Professor (1988-1992) of Biological Chemistry
  • Johns Hopkins University, School of Medicine

Awards

  • Academecian (2000-present) Awarded by Academia Sinica, Taiwan
  • Honorary Professor (2006-2008) Awarded by School of Chinese Medicine, Hong Kong Baptist University
  • C. Chester Stock Award (2003), Awarded by: Memorial Sloan-Kettering Cancer Center
  • Bruce F. Cain Memorial Award for Outstanding Preclinical Research in Cancer Chemotherapy (1997) Awarded by American Association for Cancer Research (AACR)
  • George H. Hitchings Award for Innovative Drug Design (1989) Awarded by Burroughs Wellcome Fund
  • Searle Scholar Award, Awarded by Searle Scholar Program (1981-1984)

Fingerprint Dive into the research topics where Leroy-Fong Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Type I DNA Topoisomerase Medicine & Life Sciences
Type II DNA Topoisomerase Medicine & Life Sciences
Camptothecin Medicine & Life Sciences
DNA Medicine & Life Sciences
Antineoplastic Agents Medicine & Life Sciences
Cytotoxicity Chemical Compounds
Poisons Medicine & Life Sciences
DNA Damage Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2016

105年度第二期癌症研究計畫-臺北醫學大學

Yen, Y., Whang-Peng, J., Liu, L. & Chang, W.

1/1/16 → 12/31/16

Project: A - Government Institution › c - Ministry of Health and Welfare

104年度「空中救護審核機制計畫」

Tsai, S., Whang-Peng, J., Liu, L., Chang, W., Ho, Y., Cheng, Y., Yeh, S., Chen, K., Sung, S., Hung, K., Chen, R., Chiou, H., Chen, C. & Li, Y.

1/1/15 → 3/31/16

Project: A - Government Institution › c - Ministry of Health and Welfare

Research Output 1975 2018

4 Citations (Scopus)

Inhibitory effect of Anoectochilus formosanus extract on hyperglycemia-related PD-L1 expression and cancer proliferation

Ho, Y., Chen, Y. F., Wang, L. H., Hsu, K. Y., Chin, Y. T., Yang, Y. C. S. H., Wang, S. H., Chen, Y. R., Shih, Y. J., Liu, L. F., Wang, K., Whang-Peng, J., Tang, H. Y., Lin, H. Y., Liu, H. L. & Lin, S. J., Aug 2 2018, In : Frontiers in Pharmacology. 9, AUG, 807.

Research output: Contribution to journal › Article

Obese Mice
Hyperglycemia
Blood Glucose
Metformin
Hypoglycemic Agents
3 Citations (Scopus)

Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers

Nana, A. W., Wu, S. Y., Yang, Y. C. S., Chin, Y. T., Cheng, T. M., Ho, Y., Li, W. S., Liao, Y. M., Chen, Y. R., Shih, Y. J., Liu, Y. R., Pedersen, J., Incerpi, S., Hercbergs, A., Liu, L. F., Whang-Peng, J., Davis, P. J. & Lin, H. Y., Oct 1 2018, In : Hormones and Cancer. 9, 5, p. 349-360 12 p.

Research output: Contribution to journal › Article

Colorectal Neoplasms
Oxidoreductases
Neoplasms
Integrins
Stilbenes
8 Citations (Scopus)

Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer

Nana, A. W., Chin, Y. T., Lin, C. Y., Ho, Y., Bennett, J. A., Shih, Y. J., Chen, Y. R., Changou, C. A., Pedersen, J. Z., Incerpi, S., Liu, L. F., Whang-Peng, J., Fu, E., Li, W. S., Mousa, S. A., Lin, H. Y. & Davis, P. J., Mar 1 2018, In : Endocrine-Related Cancer. 25, 3, p. 279-293 15 p.

Research output: Contribution to journal › Article

High Mobility Group Proteins
Catenins
varespladib methyl
Colonic Neoplasms
Down-Regulation

Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin [Oncotarget, 7, (2016) (27641-27654)]. DOI:10.18632/oncotarget.8505

Yang, Y. C. S. H., Chin, Y. T., Hsieh, M. T., Lai, H. Y., Ke, C. C., Crawford, D. R., Lee, O. K., Fu, E., Mousa, S. A., Grasso, P., Liu, L. F., Chang, H. Y., Tang, H. Y., Lin, H. Y. & Davis, P. J., 2017, In : Oncotarget. 8, 21, p. 35480 1 p.

Research output: Contribution to journal › Comment/debate

14 Citations (Scopus)

Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells

Hsieh, M. T., Wang, L. M., Changou, C. A., Chin, Y. T., Yang, Y. C. S. H., Lai, H. Y., Lee, S. Y., Yang, Y. N., Whang-Peng, J., Liu, L. F., Lin, H. Y., Mousa, S. A. & Davis, P. J., 2017, In : Oncotarget. 8, 15, p. 24237-24249 13 p.

Research output: Contribution to journal › Article

Thyroid Hormones
Integrins
Ovarian Neoplasms
Estrogen Receptors
Phosphorylation